Article
The homocysteine controversy
21 Jun 2010
Abstract excerpt
Mild to moderate hyperhomocysteinemia has been identified as a strong predictor of cardiovascular disease, independent from classical atherothrombotic risk factors. In the last decade, a number of large intervention trials using B vitamins have been performed and have shown no benefit of homocysteine-lowering therapy in high-risk patients. In addition, Mendelian randomization studies failed to convincingly...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
